Introduction
to Milta 2.0 technology
Milta Technologie was founded in 2006, the fruit of Guillaume Moreau's visionary passion. After acquiring in-depth knowledge of photobiomodulation (PBM) at the Energetic Institute in Moscow, Guillaume Moreau imported this promising technology to France. Focusing on therapeutic treatments, the Milta range evolved, integrating new applications and obtaining CE medical certification as a low-energy laser therapy device. In 2024, Milta launched the Milta 2.0, marking a revolution in improved performance and ergonomics, affirming its commitment to continuous innovation.
Milta Technologie's vision is to be at the cutting edge of technology, using photobiomodulation to improve quality of life without interfering directly in traditional medical processes. Our mission is to develop advanced, safe and effective technologies that support professionals in their daily practice, while strictly complying with international regulations. By focusing on research and innovation, Milta is committed to offering solutions that combine technical excellence with respect for the environment.
Features
innovative Milta 2.0
The Milta 2.0 is equipped with a range of cutting-edge technologies that take photobiomodulation to the next level. At the heart of these innovations is an advanced light emission system that combines nano-pulsed laser diodes and LEDs covering both the infrared and visible spectrum. This configuration enables light distribution, optimizing tissue exposure to the beneficial effects of light. What's more, Milta 2.0 incorporates a static magnetic field that complements the action of light for optimum synergy.
The device also features state-of-the-art control software, enabling professionals to customize procedures with precision. Thanks to an integrated Bluetooth touch tablet and Android operating system, users can easily adjust parameters such as session intensity, duration and frequency. The unlimited expert mode offers unrivalled flexibility, enabling practitioners to create tailor-made programs that specifically adapt to their professional needs.
The Milta 2.0's design is the result of meticulous attention to ergonomics and user experience. More compact and lightweight than its predecessors, this device is designed to maximize comfort for both the practitioner and those receiving treatment.
Its unibody architecture not only enhances the device's durability, but also its ease of handling during treatment. The enlarged emission surface enables greater coverage in a single application, reducing the time needed for each session and improving overall efficiency of use.
Efficiency
using Milta 2.0 technology
The Milta 2.0 is designed to simplify and optimize the daily practice of professionals. With its intuitive, customizable settings, the device enables users to prepare and perform procedures quickly and accurately.
The exclusive structural dissipation cooling system ensures that the device remains at an optimum temperature, enabling continuous sessions without the risk of overheating. This efficiency of use means less time spent preparing and managing the device, and more time spent directly with people.
35 years
ofexpertise
This therapy was designed and developed by Russian scientists and doctors specializing in aerospace medical research.
Guillaume Moreau has embarked on an exciting new adventure by training in photobiomodulation at the Moscow Energy Institute. This opportunity will enable him to explore the benefits of this emerging technology and deepen his knowledge in this promising field. This unique training opens up a bright future for him.
The Milta photobiomodulation device, renowned for its therapeutic benefits, is about to be imported from Russia. This innovative technology promises to improve users' health and well-being thanks to its regenerative properties. A new era of advanced care is upon us.
As part of a drive for innovation and development, the technology behind Milta, the famous photobiomodulation device, has been acquired to become "Milta made in France". This acquisition will localize production and strengthen national expertise in this field, opening up promising new prospects for health and well-being.
Physioquanta launches the Milta Led, a low-energy laser therapy device with multiple therapeutic benefits. Following on from its success in rehabilitation, the Milta range is expanded to include specific versions for other applications, such as skin care, hair care, gynecological care and dental care.
A major milestone has just been reached for the Milta with the award of "CE medical" certification. This attests to the photobiomodulation device's compliance with the safety and efficacy standards in force in the European Union. Users can therefore enjoy the therapeutic benefits of Milta with complete confidence.
Physioquanta has introduced the Milta Pad, a new technological breakthrough. This portable device brings photobiomodulation therapy into the home. The Milta Pad is designed for pain management and offers a practical and effective aid for relieving musculoskeletal pain and other pain-related disorders.
Milta has announced the launch of its new photobiomodulation device, the MILTA 2.0. This new model offers a host of improvements over its predecessor, in terms of both performance and ergonomics.
made
in france
Milta Technologie is the proud embodiment of French excellence in the design, development and manufacture of every device, meeting the most rigorous quality standards. Rooted in a rich heritage of innovation, the company supports the local economy by giving preference to regional suppliers and partners, thereby promoting job creation and stimulating local economic growth. This commitment also reinforces our environmental responsibility by reducing our carbon footprint, making Milta a preferred choice for those who value craftsmanship and sustainability.
